EMA – Publication of the revised Q&A to Stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use – Practical guidance on the applicable rules to centrally authorised medicinal products for human use intended to be placed on the market in Northern Ireland before and after the application of Regulation (EU) 2023/1182
The EMA revised its Q&A to Stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use – Practical guidance on the applicable rules to centrally authorised medicinal products for...





